Skip to main content
Azurity Pharmaceuticals

Director, Health Economics & Outcomes Research (HEOR)

RemoteUnited States only
Published
Role
Research
Experience
Lead
Employment
Full-time
Salary not disclosed
Check eligibility

Open to US only. Set where you work from to check your eligibility.

No BS summary

Director-level HEOR/value access leader with 8+ years in pharma, biotech, or medical device. Must own value dossiers, economic models, US reimbursement strategy, DRG/NTAP/coding work, and real-world evidence studies. Remote US role with ~20–30% travel; Canada HTA and hospital/inpatient experience strongly preferred.

What you'll do

  • Own the HEOR and value-evidence strategy for the Surgical Business Unit, beginning with D-PLEX100, and build the integrated evidence plan that supports US and Canadian access and reimbursement across the product lifecycle.
  • Identify evidence gaps against the requirements of hospital decision-makers, payers, and health-technology-assessment (HTA) bodies, and prioritize the studies and analyses needed to close them.
  • Define the economic value proposition for an inpatient, DRG-reimbursed surgical product, and align it with brand strategy and market-access objectives.
  • Lead development of value dossiers — including the AMCP dossier — and the supporting clinical and economic evidence summaries.
  • Build and maintain budget-impact and cost-effectiveness models, cost-of-care and cost-offset analyses, and account-level value calculators for institutional customers.
  • Develop payer, hospital, and P&T / value-analysis-committee value tools and objection-handling materials, and equip the field and account teams with compliant value narratives.
  • Lead the health-economic and evidence components of the New Technology Add-On Payment (NTAP) application and other inpatient add-on payment pathways, in partnership with Market Access and Program Management.
  • Develop the hospital coding and reimbursement strategy — MS-DRG mapping, HCPCS/ICD coding, and the economic case for appropriate reimbursement — and produce supporting materials for hospital finance and revenue-cycle stakeholders.
  • Model DRG economics and the payment landscape so pricing, contracting, and the value story reflect how the product is actually reimbursed in the inpatient setting.
  • Design and oversee HEOR studies — retrospective database, real-world evidence, chart review, and pragmatic analyses — using claims, EHR, and registry data, executed with internal teams and external vendors.
  • Collaborate with clinical, biostatistics, and evidence-generation colleagues on outcomes endpoints and real-world evidence, and with KOLs on study design and authorship.
  • Drive the HEOR publication and communication plan — abstracts, posters, and manuscripts for congresses such as ISPOR, AMCP, and IDWeek — to make the evidence available to decision-makers.
  • Support US field engagement with payers, hospital systems, IDNs, and population-health decision-makers, providing compliant health-economic evidence and training.
  • Develop the Canadian value-evidence and HTA strategy — CDA-AMC (formerly CADTH) and INESSS submissions, pan-Canadian considerations, and hospital / provincial access requirements — as D-PLEX100 advances in Canada.
  • Monitor evolving evidence requirements, HTA methods, and ICER-type assessments, and prepare responses.
  • Other miscellaneous job duties as required

What they require

  • Advanced degree in health economics, outcomes research, pharmacy, epidemiology, public health, or a related field (PhD, PharmD, or Master's); Bachelor's with commensurate experience considered.
  • 8+ years of HEOR, health economics, or value & access experience in pharmaceutical, biotech, or medical device.
  • Demonstrated ownership of value dossiers (including AMCP dossier) and economic models (budget-impact and cost-effectiveness).
  • Working knowledge of US reimbursement — including inpatient DRG economics, add-on payment (NTAP), and hospital coding (MS-DRG, HCPCS/ICD) — sufficient to build the economic case for a hospital-administered product.
  • Experience designing and overseeing HEOR studies using real-world data (claims, EHR, registries), including work with external vendors and academic collaborators.
  • Strong communication skills, including the ability to translate economic analysis into decision-ready value narratives for payer, hospital, and P&T audiences.
  • Proven cross-functional collaboration with Market Access, Medical Affairs, Commercial, and Clinical/Regulatory.
  • Willingness to travel ~20–30% (including congresses, advisory boards, and customer or vendor meetings).
  • Preferred: Hospital / inpatient, anti-infective, surgical, or drug-device product HEOR experience strongly preferred.
  • Preferred: Direct experience supporting an NTAP application or other inpatient add-on payment pathway.
  • Preferred: Familiarity with hospital P&T and value-analysis-committee decision-making and with antimicrobial-stewardship / infection-prevention economics.
  • Preferred: Canadian HTA experience (CDA-AMC / CADTH, INESSS) and knowledge of provincial and hospital access.
  • Preferred: HEOR experience with an in-licensed or newly acquired asset.
  • Preferred: Publication record in HEOR or health-economics venues (e.g., ISPOR, AMCP).
  • Must be able to sit for long periods of time.
  • While performing the duties of this job, the employee is frequently required to stand; walk; sit; talk and/or hear.
  • May occasionally climb stairs and/or ride elevators.
  • The employee must occasionally lift and/or move up to 25 pounds.
  • Employee must be able to manipulate keyboard, operate a telephone and hand-held devices.

Benefits

  • Competitive compensation package, including an annual bonus based on company performance.
  • Sales - In lieu of annual bonuses, an Incentive compensation program that allows you to earn more - even over plan.
  • Sales Only - car reimbursement program and gas card for both business and personal use.
  • Excellent medical, dental, vision, and prescription coverage.
  • Hybrid work model, allowing you to work two days from home and three days in the office. Excludes Sales, Manufacturing, and some Operations positions.
  • Retirement Savings Plan (401K) matching dollar for dollar up to 5%.
  • Generous time off policy, with up to 15 vacation days annually + rollover up to 40 hours.
  • Five sick/wellness days.
  • Company closes between Christmas and New Year’s for an extra week off.
  • 13 holidays over the course of the year.
  • Tuition reimbursement for undergraduate and graduate level courses or certifications.
  • Azurity High Five peer recognition platform.
Pharmaceuticals

Details

Apply routeGreenhouse
Salary not disclosed